RIPK1-IN-19 is a selective and potent bimodal RIPK1 inhibitor with IC50=15 nM that protects against cell necrosis and works well in the tnf alpha-induced Systemic Inflammatory Response Syndrome (SIRS) model and imiquimod (IMQ)-induced psoriasis model.
Molecular Weight:
496.54
Purity:
98.81%
CAS Number:
[2763831-43-0]
Formula:
C28H25FN6O2
Target:
RIP kinase
T87334
* VAT and and shipping costs not included. Errors and price changes excepted
